Diese Veranstaltung hat bereits stattgefunden


Medical Retina

3rd ESASO Module 2018
Rome, Italien
Veranstaltungsnummer: 26915
Zertifizierung: genehmigt
CME Max: 23
Gebühren ab: gebührenfrei
verfügbare Plätze: begrenzt
Sprache: Englisch

 Zum Kalender hinzufügen
  • Datum
    12.02.2018, 07:45 - 16.02.2018, 13:00
    European School for Advanced Studies in Ophthalmology ESASO
    This third module of the ESASO training courses in 2018 will focus on medical retina. International speakers will share their knowledge. The training course will take place in Rome, Italy. We have asked for new information on this event - Do you know already? If you tick this event at My Events in your Member Area, you will be informed immediately when news become available.


    Teilnehmer max.

    Gebühren ab

    Ärzte/-innen in Weiterbildung

    Teilnehmer max.

    Gebühren ab
  •     Monday, 12 February 2018 
    07:45-08:30   Registration and welcoming
        Intravitreal Injection Course
    08:30   Criteria for selection of the treatment and the protocol of treatment (disease, comorbidities, age of the patient, availabilityof the patients, organization of the hospital)
    09:15   Prevention of endophthalmitis: selection of the eye, prophylaxis treatment injection and reinjection techniques
    10:00   Controls and post-injections treatments
    10:30   COFFEE BREAK
    11:00   Generic and specific complications per pathology (DME, PDR, RVO, AMD, ROP, Coats, etc.)
    12:00   Dealing with post-intravitreal injection endophthalmitis
    13:00   LUNCH
        News In AMD Management 
    14:00   AMD: AMD treatment with intravitreal aflibercept or ranibizumab: treatment protocols, efficacy, safety and patterns of response
    15:00   PCV: from diagnosis to treatment
    15:45   COFFEE BREAK
    16:15-17:00   Myopic CNV treatment: long-term results and case study
        Tuesday, 13 February 2018 
    08:30-13:00   Industry Satellite Symposia
    13:00   LUNCH
        Imaging Course 
    14:00   DME in imaging and OCT/OCT-A: what is important to know
    14:30   OCT classification of drusen and macular atrophy - OCT features in wAMD
    15:30   COFFEE BREAK
    16:00-17:00   OCT-A features of CNV - OCT and OCT-A integrated images for management of wAMD
        Wednesday, 14 February 2018 
        Imaging Course 
    08:30   Imaging intermediate AMD and subclinical neovascularization
    08:50   Different CNV types by OCT-A and evaluation of their activity without use of fluorescein angiography
    09:10   “Smart-check” of the imaging to assess the response to AMD treatment
    09:30   OCT-A findings of PCV and changes under treatment
    09:50   OCT-A findings in CSCR, CNV in CSCR, Mactel I and II
    10:10   Clinical value of the imaging assessment of the choroid
    10:30   COFFEE BREAK
    11:00   Peculiar characteristics of myopic CNV on OCT-A and assessment of response to anti-VEGF treatment
    11:20   Managing irvine-gass: OCT assessment of macula prior and after cataract surgery and response to treatment
    11:40   Challenges in interpretation of OCT-A images in AMD
        DME In Real Life 
    12:00   New aspects of biomicroscopic modification of macular stroma and vascularization in the progression of ME
    12:30   Correlation of inflammation biomarkers and the stage of ME
    13:00   LUNCH
    14:00   DME in imaging and OCT/OCT-A: what is important to know
    14:30   Intravitreal steroids: biological and clinical differences
    15:00   COFFEE BREAK
    15:30   Real life data of DME intravitreal treatments and patients management
    16:00-16:30   Intravitreal treatment: burden for patients and payers
        Thursday, 15 February 2018 
    09:00   Use of anti-VEGF as prevention of PDR
    10:00   Anti-VEGF safety
    10:30   COFFEE BREAK
    11:00   Combining or switching treatment for DME
    11:45   Use of micropulse laser in DME treatment
    12:30   Chronic and refractory DME: definition and treatment options
    13:00   LUNCH
        Diabetic Retinopathy And RVO
    14:00   Optimized and realistic treatment of DME
    14:45   PDR treatment with anti-VEGF: beyond protocol results what is the clinical application?
    15:30   COFFEE BREAK
    16:00-17:00   Intravitreal steroids and anti-VEGF treatment of ME in RVO: Case study
        Friday, 16 February 2018 
        Uveitis Course 
    08:30   Infectious uveitis manifestations, diagnosis and treatment
    09:30   Non-infectious uveitis manifestation and diagnosis and treatment
    10:30   COFFEE BREAK
    11:00   Deliver of corticosteroids in non-infectious uveitis: systemic, intravitreal, suprachoroidal, subtenonians, subconjunctival
    11:30   Case study of infectious uveitis
    12:00   Case study of non-infectious uveitis
    12:30-13:00   Test, certificates and farewell
  • Event location is to be verified.

    European School for Advanced Studies in Ophthalmology ESASO
    c/o Università della Svizzera italiana (USI)
    Via G. Buffi 13
    CH - 6904 Lugano
    Tel.: +41 (0)58 666 46 29
    Fax: +41 (0)58 666 46 19


    Please contact the organizer for further information.